Njira zodziwira ma DNA opanda ma cell amagazi ndi mkodzo zipatsa ogwira ntchito zachipatala zida zolondola kwambiri, zosasokoneza kuti azindikire ndikuwunika matenda, kukanidwa, komanso kuopsa kwa chiwalo chomwe chiwonongeka powaika ndi odwala a COVID-19.

Eurofins Viracor, LLC, mtsogoleri pakuyesa matenda opatsirana, chitetezo chamthupi, ndi ziwengo, alengeza lero kuti alowa mgwirizano walayisensi yekha ndi Cornell University kuti agulitse zoyesa zingapo zatsopano komanso zatsopano zomwe cholinga chake ndikusintha kasamalidwe kachipatala ka COVID- 19 ndi kuwaika odwala omwe adakhudzidwa ndi kuwonongeka kwa minofu ndi matenda.

Opaleshoni ya biopsy ndiyofunikira pakutsata kuwonongeka kwa COVID-19 m'thupi, koma njirayi imatha kukhala yowawa komanso yodula kwa wodwalayo. Gulu la University of Cornell, motsogozedwa ndi Dr. Iwijn De Vlaminck, pulofesa wothandizira pa Meinig School of Biomedical Engineering, apanga njira ina yogwiritsira ntchito biopsy - buku lachidziwitso, loyesa magazi osasokoneza kuti ayese kuvulala kwa chiwalo kuchokera ku COVID-19. Mayesowa amagwiritsa ntchito DNA yopanda ma cell (cfDNA) kuti awone kuwonongeka komwe COVID-19 imawononga ma cell, minofu ndi ziwalo.

Kuphatikiza apo, cfDNA ndiwosanthula wosunthika kwambiri wowunikira zovuta zazikulu zakusintha kwa ma cell a hematopoietic (HCT) pamatenda ambiri amagazi ndi khansa, kuphatikiza Matenda a Graft-Versus-Host, matenda, kulephera kwa kumezanitsa komanso kubwereranso kwa matenda. Mgwirizano wapakati pa Eurofins Viracor ndi Cornell University udzakulitsa mwayi wopeza njira yatsopano yotsatirira magazi ya cfDNA methylation kuti azindikire msanga kapena kuneneratu za zovuta zazikulu zokhudzana ndi allogeneic HCT, motero kuwongolera chisamaliro cha odwala oika ma cell cell.

Mu ntchito ina, Eurofins Viracor ikufuna kugulitsa mayeso amtundu wa cfDNA omwe amagwiritsidwa ntchito kuti azindikire kupezeka kwa matenda a mkodzo mwa odwala omwe amaika impso ndikuwerengera kuchuluka kwa kuwonongeka kwa impso ndi chikhodzodzo.

Ndi mphamvu zophatikiza za Eurofins Viracor ndi makampani ogwirizana nawo Transplant Genomics, Inc. ndi Eurofins Donor & Product Testing, Inc. Makampani a Diagnostics kuti athe kuthana ndi zosowa zomwe sizinakwaniritsidwe panthawi yonse yosamalira odwala.

ZOMWE MUNGACHITE PA NKHANIYI:

Eurofins Viracor, LLC, mtsogoleri pakuyesa matenda opatsirana, chitetezo chamthupi, ndi ziwengo, alengeza lero kuti alowa mgwirizano walayisensi yekha ndi Cornell University kuti agulitse zoyesa zingapo zatsopano komanso zatsopano zomwe cholinga chake ndikusintha kasamalidwe kachipatala ka COVID- 19 ndi kuwaika odwala omwe adakhudzidwa ndi kuwonongeka kwa minofu ndi matenda.
Mu ntchito ina, Eurofins Viracor ikufuna kugulitsa mayeso amtundu wa cfDNA omwe amagwiritsidwa ntchito kuti azindikire kupezeka kwa matenda a mkodzo mwa odwala omwe amaika impso ndikuwerengera kuchuluka kwa kuwonongeka kwa impso ndi chikhodzodzo.
and their innovative transplant testing portfolios, the strategic collaboration with Cornell University marks another critical step in the mission of the Eurofins US Transplant Diagnostics companies to address unmet needs across the continuum of transplant patient care.